Press conference of Riocath® Global, a.s.

May 23, 2018

In the premises of the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences a press conference was held with the presence of the media, where the revolutionary discovery of Riocath® catheter was presented.

Czech company Riocath® Global, a.s. in cooperation with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences has developed and patented a revolutionary type of catheter, based on the completely unique technology.

Czech team of Riocath Global, a.s. (RIOCATH® from Reverseally Inside-Out CATHetrisation), developed and patented in collaboration with the Development Center of the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences a world-wide unique technology, widely used in tubular medical devices. One of the first clinically significant applications, where this technology is going be used, is a new form of urinary catheter. The RIOCATH® design will greatly reduce the risk of introducing infection into the body as well as the trauma of sensitive tissues. The project has invested more than two million euros from private investors. Clinical trials will begin by the end of this year. Launching is expected in 2019.

The press conference was attended by representatives of Riocath® Global, a.s., Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and medical experts.

INTRANET

RIOCATH IN MEDIA

RIOCATH® GLOBAL, A.S.

Heřmanova 24, 170 00 Praha 7

Czech Republic

CRN: 06684998

VAT ID: CZ06684998

© 2018 Riocath® Global, a.s.. All Rights Reserved